Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Claire Gibrat"'
Publikováno v:
Canadian Journal of Cardiology. 33:1668-1674
Data on the impact of coronary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) on quality of life (QOL) are limited. To date, studies have been limited in sample size and have focused on only a few domains of the Seattle Angina
Autor:
Giulia Cisbani, Claire Gibrat, Martine Saint-Pierre, Katherine Coulombe, Frédéric Calon, Ariane Giguère-Rancourt, Isabelle St-Amour, Francesca Cicchetti
Publikováno v:
The Journal of Nutritional Biochemistry. 30:133-142
Pre-clinical data collected in mouse models of Parkinson's disease (PD) support the neuroprotective potential of omega-3 polyunsaturated fatty acids (n-3 PUFA)-enriched diet on the dopaminergic (DAergic) system. In this study, we investigated the eff
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 12(15)
Aims Septal surfing and distal tip injections are two techniques used for septal crossing in retrograde chronic total occlusion (CTO) percutaneous coronary interventions (PCI). The aim of this study was to examine for the first time the safety and fe
Publikováno v:
Circulation: Cardiovascular Interventions. 9
Background— The prevalence of native coronary chronic total occlusions (CTOs) after coronary artery bypass grafts (CABGs) is higher than in non-CABG population. We examined outcomes of CTO percutaneous coronary intervention (PCI) post-CABG versus w
Autor:
Can Manh Nguyen, Omar Abdul-Jawad Altisent, Luis Nombela-Franco, Henrique Barbosa Ribeiro, Rustem Dautov, Stéphane Rinfret, Claire Gibrat
Publikováno v:
The American journal of cardiology. 118(6)
The experience with the transradial approach in percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) in the United States is limited. We looked at the safety and feasibility of a home-made sheathless transradial technique (STT)
Publikováno v:
JACC: Cardiovascular Interventions. 9(4)
The use of the transradial approach (TRA) in percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) is still limited. We describe one of the largest single-center experiences, which evolved from 6F to a novel sheathless technique
Autor:
Claude Rouillard, Frédéric Calon, Mélissa Ouellet, Mélanie Bousquet, Francesca Cicchetti, Claire Gibrat
Publikováno v:
Journal of Neurochemistry. 114:1651-1658
Cystamine has shown significant neuroprotective properties in preclinical studies of Parkinson's disease (PD) and Huntington's disease (HD). Cysteamine, its FDA-approved reduced form, is scheduled to be tested for clinical efficacy in HD patients. He
Autor:
Claire Gibrat, Carl Julien, Francesca Cicchetti, Mélanie Bousquet, Martine Saint-Pierre, Frédéric Calon
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33:1401-1408
While we recently reported the beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) in a mouse model of Parkinson's disease (PD), the mechanisms of action remain largely unknown. Here, we specifically investigated the contribution of
Autor:
Mélanie Bousquet, Claude Rouillard, Daniel Lévesque, Francesca Cicchetti, Claire Gibrat, Martine Saint-Pierre
Publikováno v:
Journal of Neurochemistry. 109:1469-1482
Animal models are invaluable tools to study neurodegenerative disorders but a general consensus on the most accurate rodent model of Parkinson's disease has not been reached. Here, we examined how different methods of MPTP administration influence th
Autor:
Claire Gibrat, Julien Charest, S. Badrinarayanan, L. Boivin, M H Lavallée-Bourget, Janelle Drouin-Ouellet, Manon Lebel, Giulia Cisbani, Martine Saint-Pierre, Marie Lagacé, Martin Lévesque, Audrey Chabrat, Francesca Cicchetti, Mélanie Bousquet
Publikováno v:
Neurobiology of Disease; 82, pp 430-444 (2015)
Neurobiology of Disease, Vol 82, Iss, Pp 430-444 (2015)
Neurobiology of Disease, Vol 82, Iss, Pp 430-444 (2015)
The neuroprotective properties of cystamine identified in pre-clinical studies have fast-tracked this compound to clinical trials in Huntington's disease, showing tolerability and benefits on motor symptoms. We tested whether cystamine could have suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28a00c078516f3eca194d03b4b4da1c
https://lup.lub.lu.se/record/7845059
https://lup.lub.lu.se/record/7845059